Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial

Author： Ahmadieh Hamid

Publisher： Springer Publishing Company

ISSN： 0721-832X

Source： Graefe's Archive for Clinical and Experimental Ophthalmology, Vol.246, Iss.4, 2008-04, pp. : 483-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal bevacizumab treatment for refractory diabetic macular edema

By Yuksel Erdem Ozdek Sengul Yuksel Nılay Hasanreisoglu Berati

International Ophthalmology, Vol. 33, Iss. 6, 2013-12 ,pp. : 659-663

Springer Publishing Company

Access to resources Recommend Favorite

Ischemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edema

By Goel Neha

International Ophthalmology, Vol. 31, Iss. 1, 2011-02 ,pp. : 39-42

Springer Publishing Company

Access to resources Recommend Favorite

Pattern electroretinogram for monitoring the efficacy of intravitreal triamcinolone injection in diabetic macular edema

By Ozkiris Abdullah Evereklioglu Cem Oner Ayse Erkiliç Kuddusi

Documenta Ophthalmologica, Vol. 109, Iss. 2, 2004-09 ,pp. : 139-145

Springer Publishing Company

Access to resources Recommend Favorite

The role of macular hydration in the evaluation of the effect of intravitreal triamcinolone on visual acuity in eyes with diabetic macular edema

By Sonmez Kenan

International Ophthalmology, Vol. 33, Iss. 1, 2013-02 ,pp. : 15-25

Springer Publishing Company

Access to resources Recommend Favorite

Single injection of triamcinolone versus three repeated injections of bevacizumab for treatment of diabetic macular edema

By Taş Mehmet

International Ophthalmology, Vol. 33, Iss. 4, 2013-08 ,pp. : 375-380

Springer Publishing Company

Access to resources Recommend Favorite